Status:
RECRUITING
Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Interstitial Lung Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Interstitial lung diseases (ILDs) are common chronic disease characterized by high mortality and morbidity, also linked to cardiovascular implication. Cardiovascular complications, occur early in idio...
Eligibility Criteria
Inclusion
- • Adult subjects (\>18 y.o.) with previously known ILD or high likelihood for having ILD including CTD diagnosis since at least 5 years before the project starts in order to increase the prevalence of ILD \[2\] who signed an Informed Consent authorizing data collection.
Exclusion
- Subjects with active infectious disease;
- known CAD;
- history of previous percutaneous or surgical revascularization;
- known cardiomyopathy;
- previous heart failure;
- presence of cardiac devices (prosthetic valve, ICD, PM, ICD-CRT, LVAD)
- previous or active neoplasia;
- pregnancy and breastfeeding;
- allergy to iodine contrast agent;
- claustrophobia;
- glomerular filtration rate \< 30mL/min
- impossibility to lay down or breath old
- absence of informed consent signed
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT06537934
Start Date
September 1 2024
End Date
September 1 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132